MDS Nordion and Macrocyclics Inc. have entered into a research and development collaboration to develop innovative bifunctional chelates for use in molecular imaging and targeted therapeutic pharmaceuticals.
For more information please see the News Release
|
|
||
 All Rights Reserved. 
|
||
